loading...

Bowel Endometriosis Syndrome Score (BENS Score)

Riiskjær M; Egekvist AG; Hartwell D; Forman A; Seyer-Hansen M; Kesmodel US

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

  • Published in 2017
Authors

Riiskjær M; Egekvist AG; Hartwell D; Forman A; Seyer-Hansen M; Kesmodel US

Copyright
BENS Score © Riiskjær, 2017
Objective
To identify women with BENS and to monitor the effect of medical and surgical treatment of women suffering from bowel endometriosis
Therapeutic area
  • Female Urogenital Diseases and Pregnancy Complications
Therapeutic indication

Endometriosis

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the UK
  • Danish for Denmark
Bibliographic reference(s) of the original questionnaire

Riiskjær M, Egekvist AG, Hartwell D, Forman A, Seyer-Hansen M, Kesmodel US. Bowel Endometriosis Syndrome: a new scoring system for pelvic organ dysfunction and quality of life. Hum Reprod. 2017 Sep 1;32(9):1812-1818 (Full text article)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Riiskjær M; Egekvist AG; Hartwell D; Forman A; Seyer-Hansen M; Kesmodel US

Dr. Mads Riiskjær
Johan Langes Vej 13
8000 Aarhus C
Denmark
E-mail: riiskjaer@clin.au.dk

Mads Riiskjær's publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the UK
  • Danish for Denmark

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us